Gustafson Kurt A
Director at XNCR; Officer at OABI; EVP & Chief Financial Officer at SPECTRUM PHARMACEUTICALS INC
- Sold, on record
- $2M
- Dollars the filings state
- Form 4 sales
- 32
- Latest Jun 15, 2026
- Form 144 notices
- 13
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- XNCRXencor IncDirector
- OABIOmniAb, Inc.Officer
- SPECTRUM PHARMACEUTICALS INCEVP & Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SPECTRUM PHARMACEUTICALS INC228,919 shares
- OABI131,588 shares
- XNCR24,970 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice OABINoticeDec 8, 2025 2025
Filed to sell 23,922 shares ($47k)
Gustafson Kurt A, Officer
No 10b5-1 plan2x usual sizeFiling
- 2 Form 4 sale OABINo planDec 8, 2025 same day
Sold 23,922 shares at $1.96 ($47k)
Gustafson Kurt A, Executive VP, Finance and CFO
No 10b5-1 planSold 8.6% of holdings ($542k position)252,688 shares left2x usual sizeFollows a Form 144Filing
- 3 Form 4 sale OABINo planFeb 17, 2026 +71 days
Sold 6,828 shares at $1.70 ($12k)
Gustafson Kurt A, Executive VP, Finance and CFO
No 10b5-1 planSold 2.6% of holdings ($453k position)259,402 shares left0.6x usual sizeFollows a Form 144Filing
- 4 Form 144 notice OABINoticeFeb 17, 2026 same day
Filed to sell 16,064 shares ($27k)
Gustafson Kurt A, Officer
No 10b5-1 plan1.3x usual sizeFiling
- 5 Form 4 sale OABINo planFeb 18, 2026 +1 day
Sold 9,301 shares at $1.71 ($16k)
Gustafson Kurt A, Executive VP, Finance and CFO
No 10b5-1 planSold 3.3% of holdings ($476k position)268,851 shares left0.8x usual sizeFollows a Form 144Filing
- 6 Form 4 sale OABINo planApr 7, 2026 +48 days
Sold 6,913 shares at $1.49 ($10k)
Gustafson Kurt A, Executive VP, Finance and CFO
No 10b5-1 planSold 2.6% of holdings ($400k position)261,483 shares left0.7x usual sizeFiling
- 7 Form 144 notice OABINoticeApr 7, 2026 same day
Filed to sell 6,913 shares ($10k)
Gustafson Kurt A, Officer
No 10b5-1 plan0.7x usual sizeFiling
- 8 Form 4 sale XNCRRoutineJun 15, 2026 +69 days
Sold 5,474 shares at $12.31 ($67k)
Gustafson Kurt A, Director
10b5-1 planSold 27.1% of holdings ($248k position)14,709 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (45)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17, 2026 | XNCR | Director | Form 4 sale | 5,474 | $67k | 27.1% | Routine | SEC |
| Apr 7, 2026 | Apr 7, 2026 | OABI | Officer | Form 144 notice | 6,913 | $10k | Notice | SEC | |
| Apr 7, 2026 | Apr 7, 2026 | OABI | Executive VP, Finance and CFO | Form 4 sale | 6,913 | $10k | 2.6% | No plan | SEC |
| Feb 18, 2026 | Feb 18, 2026 | OABI | Executive VP, Finance and CFO | Form 4 sale | 9,301 | $16k | 3.3% | No plan | SEC |
| Feb 17, 2026 | Feb 17, 2026 | OABI | Officer | Form 144 notice | 16,064 | $27k | Notice | SEC | |
| Feb 17, 2026 | Feb 17, 2026 | OABI | Executive VP, Finance and CFO | Form 4 sale | 6,828 | $12k | 2.6% | No plan | SEC |
| Dec 8, 2025 | Dec 9, 2025 | OABI | Executive VP, Finance and CFO | Form 4 sale | 23,922 | $47k | 8.6% | No plan | SEC |
| Dec 8, 2025 | Dec 8, 2025 | OABI | Officer | Form 144 notice | 23,922 | $47k | Notice | SEC | |
| Jun 16, 2025 | Jun 16, 2025 | XNCR | Director | Form 4 sale | 2,993 | $28k | 12.9% | Routine | SEC |
| Jun 16, 2025 | Jun 16, 2025 | XNCR | Director | Form 144 notice | 2,993 | $28k | Notice | SEC | |
| Apr 7, 2025 | Apr 7, 2025 | OABI | Officer | Form 144 notice | 7,206 | $14k | Notice | SEC | |
| Apr 7, 2025 | Apr 7, 2025 | OABI | Executive VP, Finance and CFO | Form 4 sale | 7,206 | $14k | 3.1% | No plan | SEC |
| Apr 1, 2025 | Apr 1, 2025 | OABI | Officer | Form 144 notice | 11,963 | $28k | Notice | SEC | |
| Apr 1, 2025 | Apr 1, 2025 | OABI | Executive VP, Finance and CFO | Form 4 sale | 11,963 | $28k | 5.2% | No plan | SEC |
| Feb 19, 2025 | Feb 19, 2025 | OABI | Executive VP, Finance and CFO | Form 4 sale | 7,255 | $27k | 3.4% | No plan | SEC |
| Feb 18, 2025 | Feb 18, 2025 | OABI | Officer | Form 144 notice | 5,188 | $19k | Notice | SEC | |
| Jan 21, 2025 | Jan 22, 2025 | OABI | Executive VP, Finance and CFO | Form 4 sale | 15,526 | $50k | 6.8% | No plan | SEC |
| Jan 21, 2025 | Jan 21, 2025 | OABI | Officer | Form 144 notice | 15,526 | $50k | Notice | SEC | |
| Dec 9, 2024 | Dec 10, 2024 | OABI | Executive VP, Finance and CFO | Form 4 sale | 23,871 | $99k | 10.6% | No plan | SEC |
| Dec 9, 2024 | Dec 9, 2024 | OABI | Officer | Form 144 notice | 23,871 | $98k | Notice | SEC | |
| Sep 27, 2024 | Oct 1, 2024 | XNCR | Director | Form 4 sale | 2,503 | $52k | 20.9% | No plan | SEC |
| Sep 27, 2024 | Sep 27, 2024 | XNCR | Director | Form 144 notice | 2,503 | $52k | Notice | SEC | |
| Apr 8, 2024 | Apr 9, 2024 | OABI | Executive VP, Finance and CFO | Form 4 sale | 6,954 | $37k | 3.8% | No plan | SEC |
| Apr 8, 2024 | Apr 8, 2024 | OABI | Officer | Form 144 notice | 6,954 | $37k | Notice | SEC | |
| Apr 1, 2024 | Apr 2, 2024 | OABI | Executive VP, Finance & CFO | Form 4 sale | 11,849 | $65k | 6.5% | No plan | SEC |
| Apr 1, 2024 | Apr 1, 2024 | OABI | Officer | Form 144 notice | 11,849 | $65k | Notice | SEC | |
| Mar 6, 2024 | Mar 7, 2024 | XNCR | Director | Form 4 sale | 14,000 | $325k | 70.0% | Unusual | SEC |
| Mar 6, 2024 | Mar 6, 2024 | XNCR | Director | Form 144 notice | 14,000 | $324k | Notice | SEC | |
| Mar 16, 2022 | Mar 16, 2022 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 36,971 | $26k | 10.4% | Plan not stated | SEC |
| Feb 24, 2022 | Feb 24, 2022 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 36,173 | $24k | 9.3% | Unusual | SEC |
| Mar 16, 2021 | Mar 17, 2021 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 36,683 | $134k | 8.4% | Unusual | SEC |
| Feb 22, 2021 | Feb 23, 2021 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 8,672 | $32k | 1.9% | Plan not stated | SEC |
| Jan 20, 2021 | Jan 20, 2021 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 4,526 | $18k | 1.4% | Plan not stated | SEC |
| Dec 14, 2020 | Dec 16, 2020 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 25,696 | $128k | 7.1% | Unusual | SEC |
| Apr 1, 2020 | Apr 2, 2020 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 7,461 | $17k | 2.0% | Plan not stated | SEC |
| Feb 20, 2020 | Feb 21, 2020 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 8,066 | $23k | 3.8% | Plan not stated | SEC |
| Jan 17, 2020 | Jan 17, 2020 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 4,143 | $14k | 1.8% | Plan not stated | SEC |
| Apr 1, 2019 | Apr 1, 2019 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 10,616 | $114k | 4.3% | Unusual | SEC |
| Mar 26, 2019 | Mar 27, 2019 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 926 | $9k | 0.4% | Plan not stated | SEC |
| Mar 25, 2019 | Mar 25, 2019 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 3,797 | $36k | 1.5% | Plan not stated | SEC |
| Jan 16, 2019 | Jan 18, 2019 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 3,207 | $33k | 1.5% | Plan not stated | SEC |
| Jan 11, 2019 | Jan 11, 2019 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 33,692 | $366k | 13.3% | Unusual | SEC |
| Mar 28, 2018 | Mar 28, 2018 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 4,350 | $71k | 2.3% | Plan not stated | SEC |
| Mar 26, 2018 | Mar 27, 2018 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 1,300 | $23k | 0.7% | Plan not stated | SEC |
| Mar 22, 2018 | Mar 23, 2018 | SPECTRUM PHARMACEUTICALS INC | EVP & Chief Financial Officer | Form 4 sale | 2,640 | $48k | 1.4% | Plan not stated | SEC |